BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8055450)

  • 1. Ductal carcinoma in situ of the male breast.
    Camus MG; Joshi MG; Mackarem G; Lee AK; Rossi RL; Munson JL; Buyske J; Barbarisi LJ; Sanders LE; Hughes KS
    Cancer; 1994 Aug; 74(4):1289-93. PubMed ID: 8055450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
    Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer].
    Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the male breast. Analysis of 31 cases.
    Cutuli B; Dilhuydy JM; De Lafontan B; Berlie J; Lacroze M; Lesaunier F; Graic Y; Tortochaux J; Resbeut M; Lesimple T; Gamelin E; Campana F; Reme-Saumon M; Moncho-Bernier V; Cuilliere JC; Marchal C; De Gislain G; N'Guyen TD; Teissier E; Velten M
    Eur J Cancer; 1997 Jan; 33(1):35-8. PubMed ID: 9071896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In situ ductal carcinoma of the breast: current status and our experience].
    Friedman D; Sorice G; Baccini P; Varcada M; Percoco P; Bachi V
    Ann Ital Chir; 1999; 70(1):37-43; discussion 44. PubMed ID: 10367505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should axillary dissection be performed in patients with DCIS?
    Wood WC
    Ann Surg Oncol; 1995 May; 2(3):193-4. PubMed ID: 7641013
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In situ ductal carcinoma of the breast].
    Peña-Estévez VL; Aguilar U; Torrescano Granillo A
    Ginecol Obstet Mex; 1999 Feb; 67():43-9. PubMed ID: 10327763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment analysis of 26 patients with breast ductal carcinoma in situ].
    Zhang LB; Xu YX; Geng JL; Zhang YH
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):195-7. PubMed ID: 12795854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ-associated nipple discharge: a clinical marker for locally extensive disease.
    Bauer RL; Eckhert KH; Nemoto T
    Ann Surg Oncol; 1998; 5(5):452-5. PubMed ID: 9718176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease.
    Cheng L; Al-Kaisi NK; Gordon NH; Liu AY; Gebrail F; Shenk RR
    J Natl Cancer Inst; 1997 Sep; 89(18):1356-60. PubMed ID: 9308705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical therapy of primary breast carcinoma--options and perspectives].
    Büchels HK
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1207-11. PubMed ID: 9574380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duct carcinoma in situ: biological implications for clinical practice.
    Lagios MD
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):6-11. PubMed ID: 8614847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens.
    Mai KT; Yazdi HM; Ford JC; Matzinger FR
    Eur J Surg Oncol; 2000 Nov; 26(7):646-51. PubMed ID: 11078610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma--a preliminary report.
    Hittmair AP; Lininger RA; Tavassoli FA
    Cancer; 1998 Nov; 83(10):2139-49. PubMed ID: 9827718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.